Medigo (not to be mistaken for German Berlin-based medical travel startup of the same name), an Indonesia Jakarta-based health-tech startup that was founded in May 2018, recently announced that it has raised seed funding from Venturra Discovery, the new seed investment arm of Venturra Capital.
Venturra Capital has investments in tech startups in the Southeast Asian region across different industries and notably, is an investor in Prenetics, a Hong Kong and London-headquartered genetics and digital health company.
What they do
The startup focuses on connecting healthcare facilities with the mission to “build a better, more connected Indonesian digital healthcare ecosystem”. Medigo plans to do this by targeting hospitals, clinics, and also Puskesmas (the local community health clinics) as users of their platform, seeking to connect them with their patients, doctors, and supporting partners such as insurance as well as the government.
One of Medigo’s products for healthcare providers in Indonesia is an outpatient management platform for hospitals to manage their polyclinics operations such as registrations, queue, patient slots, and doctors schedule through an API connection.
For clinics, Medigo provides an integrated clinic management application called Medigo Qlinik, that is aimed towards clinics owner or management to digitise their operations.
A soon-to-be-launched app is being developed for patients to connect to doctors practicing in Medigo’s clinic and hospital partners. Patients can register, book consultations, check medical reports and pay for consultations and medicine.
The pilot phase of Medigo is running in local hospitals Rumah Sakit Pertamina Pusat (RSPP), Rumah Sakit Pertamina Jaya (RSPJ) (both in Jakarta), and over 100 clinics. For 2019, the startup aims to partner with 10 hospitals, 500 clinics, to get to 3 million interactions between patients and doctors.
What’s the trend
Medigo highlighted in a statement that most of more than 2800 hospitals in Indonesia are not yet connected to their doctors and patients. Most of more than the 18,000 clinics in Indonesia have no common operating standards and processes are still manual. Challenges in the Indonesian healthcare industry include interoperability in all levels of healthcare facilities from Puskesmas, clinics, to hospitals.
Another health-tech platform that hails from Indonesia, Halodoc, announced in March 2019 that it has raised $65M in a series B funding led by new investor UOB Venture Management. Halodoc’s app includes services such as teleconsultation with healthcare professionals and delivery of pharmaceuticals. With the aim to improve access to healthcare and medicine in Indonesia through its app, Halodoc currently has 20,000 doctors and 1,000 pharmacies in its partner network. It currently has about 2 million users.
On the record
“Medigo believes that the real problems in the Indonesian healthcare industry are not patient-side, but on the providers’ side. The healthcare industry is highly regulated, very bureaucratic, and complex. We aim to solve problems for providers first. Without solving those problems, it’s tough to provide quality service and experience to patients,” said Harya Bimo, CEO of Medigo in a statement.